Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
Markovic SN, Geyer SM, Dawkins F, Sharfman W, Albertini M, Maples W, Fracasso PM, Fitch T, Lorusso P, Adjei AA, Erlichman C. Markovic SN, et al. Among authors: maples w. Cancer. 2005 Jun 15;103(12):2584-9. doi: 10.1002/cncr.21108. Cancer. 2005. PMID: 15887220 Free article. Clinical Trial.
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH, Petersen IA, Shives TC, Mahoney MR, Rock MG, Haddock MG, Sim FH, Maples WJ, O'Connor MI, Gunderson LL, Foo ML, Pritchard DJ, Buckner JC, Stafford SL. Edmonson JH, et al. Cancer. 2002 Feb 1;94(3):786-92. doi: 10.1002/cncr.10259. Cancer. 2002. PMID: 11857314 Free article. Clinical Trial.
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study.
Merchan JR, Qin R, Pitot H, Picus J, Liu G, Fitch T, Maples WJ, Flynn PJ, Fruth BF, Erlichman C. Merchan JR, et al. Among authors: maples wj. Cancer Chemother Pharmacol. 2015 Mar;75(3):485-93. doi: 10.1007/s00280-014-2668-5. Epub 2015 Jan 3. Cancer Chemother Pharmacol. 2015. PMID: 25556030 Free PMC article. Clinical Trial.
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
Okuno S, Petersen I, Shives T, Mahoney M, Haddock M, Sim F, O'Connor MI, Markovic SN, Maples W. Okuno S, et al. Among authors: maples w. Am J Clin Oncol. 2016 Apr;39(2):204-9. doi: 10.1097/COC.0000000000000038. Am J Clin Oncol. 2016. PMID: 24487418 Free PMC article. Clinical Trial.
Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC 3rd, McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Goh BC, Tang H, Ivy SP, Erlichman C; Endocrine Malignancies Disease Oriented Group; Mayo Clinic Cancer Center; Mayo Phase 2 Consortium. Bible KC, et al. Lancet Oncol. 2010 Oct;11(10):962-72. doi: 10.1016/S1470-2045(10)70203-5. Epub 2010 Sep 17. Lancet Oncol. 2010. PMID: 20851682 Free PMC article. Clinical Trial.
Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.
Bolton JS, O'Connell MJ, Mahoney MR, Farr GH Jr, Fitch TR, Maples WJ, Nagorney DM, Rubin J, Fuloria J, Steen PD, Alberts SR. Bolton JS, et al. Clin Colorectal Cancer. 2012 Mar;11(1):31-7. doi: 10.1016/j.clcc.2011.03.029. Epub 2011 May 13. Clin Colorectal Cancer. 2012. PMID: 21729678 Free PMC article. Clinical Trial.
75 results